Comentario editorial
Imatinib: una nueva herramienta para el manejo de la enfermedad del injerto contra el hospedador crónica esclerodermiforme
Imatinib: A New Tool for the Management of Chronic Sclerodermatous Graft-Vs-Host Disease
C. Ferrándiz-Pulido
Servicio de Dermatología, Hospital Universitario Vall d’Hebron, Barcelona Sección: Comentario Editorial
Leído
5092
Vecesse ha leído el artículo
2008
Total PDF
3084
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 7 | 38 | 15 | 53 |
| 2025 6 | 44 | 16 | 60 |
| 2025 5 | 53 | 29 | 82 |
| 2025 4 | 53 | 30 | 83 |
| 2025 3 | 79 | 19 | 98 |
| 2025 2 | 73 | 36 | 109 |
| 2025 1 | 33 | 25 | 58 |
| 2024 12 | 43 | 26 | 69 |
| 2024 11 | 49 | 65 | 114 |
| 2024 10 | 46 | 52 | 98 |
| 2024 9 | 34 | 17 | 51 |
| 2024 8 | 46 | 43 | 89 |
| 2024 7 | 56 | 28 | 84 |
| 2024 6 | 62 | 29 | 91 |
| 2024 5 | 43 | 29 | 72 |
| 2024 4 | 53 | 28 | 81 |
| 2024 3 | 43 | 25 | 68 |
| 2024 2 | 46 | 33 | 79 |
| 2024 1 | 35 | 22 | 57 |
| 2023 12 | 35 | 14 | 49 |
| 2023 11 | 41 | 32 | 73 |
| 2023 10 | 50 | 26 | 76 |
| 2023 9 | 45 | 22 | 67 |
| 2023 8 | 40 | 13 | 53 |
| 2023 7 | 53 | 39 | 92 |
| 2023 6 | 48 | 21 | 69 |
| 2023 5 | 72 | 20 | 92 |
| 2023 4 | 63 | 22 | 85 |
| 2023 3 | 52 | 36 | 88 |
| 2023 2 | 57 | 25 | 82 |
| 2022 1 | 46 | 25 | 71 |
| 2022 12 | 43 | 37 | 80 |
| 2022 11 | 49 | 36 | 85 |
| 2022 10 | 56 | 46 | 102 |
| 2022 9 | 46 | 60 | 106 |
| 2022 8 | 44 | 58 | 102 |
| 2022 7 | 50 | 50 | 100 |
| 2022 6 | 46 | 43 | 89 |
| 2022 5 | 46 | 47 | 93 |
| 2022 4 | 46 | 33 | 79 |
| 2022 3 | 51 | 50 | 101 |
| 2022 2 | 40 | 27 | 67 |
| 2021 1 | 41 | 37 | 78 |
| 2021 12 | 33 | 38 | 71 |
| 2021 11 | 49 | 42 | 91 |
| 2021 10 | 100 | 48 | 148 |
| 2021 9 | 63 | 43 | 106 |
| 2021 8 | 66 | 31 | 97 |
| 2021 7 | 52 | 23 | 75 |
| 2021 6 | 33 | 25 | 58 |
| 2021 5 | 31 | 31 | 62 |
| 2021 4 | 29 | 66 | 95 |
| 2021 3 | 71 | 22 | 93 |
| 2021 2 | 54 | 22 | 76 |
| 2020 1 | 33 | 16 | 49 |
| 2020 12 | 29 | 14 | 43 |
| 2020 11 | 37 | 25 | 62 |
| 2020 10 | 32 | 15 | 47 |
| 2020 9 | 43 | 13 | 56 |
| 2020 8 | 22 | 22 | 44 |
| 2020 7 | 21 | 13 | 34 |
| 2020 6 | 34 | 29 | 63 |
| 2020 5 | 23 | 28 | 51 |
| 2020 4 | 24 | 15 | 39 |
| 2020 3 | 24 | 15 | 39 |
| 2020 2 | 1 | 0 | 1 |
| 2020 1 | 4 | 0 | 4 |
| 2019 12 | 4 | 0 | 4 |
| 2019 11 | 13 | 2 | 15 |
| 2019 9 | 4 | 0 | 4 |
| 2019 8 | 4 | 0 | 4 |
| 2019 7 | 6 | 0 | 6 |
| 2019 6 | 4 | 0 | 4 |
| 2019 5 | 4 | 3 | 7 |
| 2019 4 | 2 | 0 | 2 |
| 2019 2 | 4 | 0 | 4 |
| 2019 1 | 1 | 2 | 3 |
| 2018 12 | 2 | 0 | 2 |
| 2018 11 | 1 | 2 | 3 |
| 2018 10 | 2 | 0 | 2 |
| 2018 9 | 2 | 0 | 2 |
| 2018 8 | 0 | 1 | 1 |
| 2018 7 | 1 | 0 | 1 |
| 2018 6 | 2 | 0 | 2 |
| 2018 5 | 2 | 1 | 3 |
| 2018 4 | 29 | 11 | 40 |
| 2018 3 | 0 | 1 | 1 |
| 2018 2 | 0 | 3 | 3 |
Mostrar todo
